Drug Design
Drug design aims to create molecules with desired therapeutic properties, accelerating the often lengthy and costly drug discovery process. Current research heavily utilizes machine learning, employing various architectures like graph neural networks, transformers, variational autoencoders, and diffusion models, often integrated with reinforcement learning and evolutionary algorithms to optimize molecule generation and predict properties such as binding affinity and synthesizability. This field is crucial for advancing healthcare, enabling the development of more effective and personalized treatments for a wide range of diseases by efficiently exploring the vast chemical space of potential drug candidates.
Papers
ACEGEN: Reinforcement learning of generative chemical agents for drug discovery
Albert Bou, Morgan Thomas, Sebastian Dittert, Carles Navarro Ramírez, Maciej Majewski, Ye Wang, Shivam Patel, Gary Tresadern, Mazen Ahmad, Vincent Moens, Woody Sherman, Simone Sciabola, Gianni De Fabritiis
DrugLLM: Open Large Language Model for Few-shot Molecule Generation
Xianggen Liu, Yan Guo, Haoran Li, Jin Liu, Shudong Huang, Bowen Ke, Jiancheng Lv